Align Technology, Inc.
- Jurisdiction
United States - LEI
549300N5YSE0U3LCP840 - ISIN
US0162551016 (ALGN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€202.75 78.0% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. Read full profile
Fundamentals
- Net revenue
€3.38B - Gross margin
69.8% - EBIT
€512.27M - EBIT margin
15.1% - Net income
€373.26M - Net margin
11.0%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| HOGAN JOSEPH M | PRESIDENT AND CEO |
|
|
|
|
| Coletti Julie Ann | EVP, CHIEF LEGAL & REGULATORY |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | May 8, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | March 27, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | March 6, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| François Rochon |
|
|
|
Buy |
| Cathie Wood |
|
|
|
Sell |
| Ray Dalio |
|
|
|
Sell |